AFLAC Incorporated with ticker code (AFL) have now 12 analysts in total covering the stock. The consensus rating is pointing to ‘Hold’. The target price High/Low ranges between 80 and 57 calculating the mean target price we have $71.67. Given that the stocks previous close was at $62.48 and the analysts are correct then there would likely be a percentage uptick in value of 14.7%. It’s also worth noting that there is a 50 day moving average of $69.29 while the 200 day moving average is $63.84. The market capitalization for the company is $38,251m. Visit the company website at: https://www.aflac.com
The potential market cap would be $43,877m based on the market consensus.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
The company has a dividend yield of 2.74% with the ex dividend date set at 14-2-2023 (DMY).
Other points of data to note are a P/E ratio of 9.3, revenue per share of 30.72 and a 2.09% return on assets.
